Skip to content

Evaluation of Novel Noise Reduction Principles in Hearing Instruments

Evaluation of Novel Noise Reduction Principles in Hearing Instruments to Determine Their Applicability.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05582408
Enrollment
26
Registered
2022-10-17
Start date
2022-09-12
Completion date
2022-11-01
Last updated
2022-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Loss

Brief summary

In the study, the speech intelligibility in noise (Outcome) between a novel noise reduction algorithm (Intervention) versus the standard noise reduction (Comparator) will be tested in adults with a N3-N4 hearing loss (Population) using streamed signals via hearing aids.

Interventions

DEVICEMeasures of Standard Noise Reduction NR1

Each participant will be fitted with the Standard Noise Reduction (NR1)

DEVICEMeasures of Noise Reduction Principle NR2

Each participant will be fitted with the novel Noise Reduction principle NR2 on the same hearing aid

DEVICEMeasure of Noise Reduction Principle NR3

Each participant will be fitted with the novel Noise Reduction principle NR3 on the same hearing aid

Sponsors

Sonova AG
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Minimum age for men: 18 years, minimum age for wom-en: 64 years, hearing aid users, * Written and spoken German, * Hearing loss range: N3-N4 Hearing loss (sensorineural) * Healthy outer ear, * Ability to understand and follow the instruction of the in-vestigator * Informed consent as documented by signature.

Exclusion criteria

* Clinical contraindications 1) hearing loss is not within the fitting range of the hearing aid, 2) acute tinnitus, 3) de-formity of the ear (closed ear canal or absence of pinna), and 4) neural hearing loss i.e., retro-cochlear pathologies such as absent / non-viable auditory nerve * Pregnant or breastfeeding women * Age \>85 years * known hypersensitivity or allergy, * limited mobility and not able to attend the appointments

Design outcomes

Primary

MeasureTime frameDescription
Difference in speech reception thresholds (SRTs) in noise between novel noise reduction algorithm (NR2) and the standard noise reduction (NR1; Comparator)4 weeksSRTs are measured with the OLSA test.

Secondary

MeasureTime frameDescription
Evaluation whether the novel noise reduction algorithm (NR3) provides different SRTs in noisy situation with speech from front compared to the current implemented standard noise reduction (NR1; Comparator)4 weeksSRTs are measured with the OLSA test.
Evaluation of subjectively different sound quality attributes/dimensions of the novel noise reduction algorithms versus standard noise reduction (Comparator)4 weeksThe sound quality ratings will be assessed with the aid of a Multi-Stimulus Test.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026